Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 760

Collective Health cruises to $205m round

The enterprise health plan software provider has now raised more than $430m in total, with SoftBank Vision Fund leading a round that also featured GV.

Jun 18, 2019

Minute Media wins $40m

The sports content publishing platform increased its overall funding to $120m with a ProSiebenSat.1-backed round that will enable it to extend its M&A activities.

Jun 18, 2019

PeopleFund crowds in extra series B financing

Peer-to-peer lending platform PeopleFund has added $5m of equity and $30m of debt to a series B round that already included contributions from KakaoPay and Dayli Financial.

Jun 18, 2019

Traction Guest signs in $13m

Salesforce Ventures has invested in Traction Guest, developer of a digital corporate sign-in system, as part of its series A round.

Jun 17, 2019

CreatorIQ scores $12m in series B round

Unilever Ventures contributed to the infleuncer marketing platform's latest round, which was led by growth equity firm TCV Capital.

Jun 17, 2019

Daily deal net: June 17, 2019

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Jun 17, 2019

Hyundai helps hike Aurora series B to $600m

Hynudai and Kia Motors took part in a tranche that expanded the driverless car technology developer's latest round, which includes Shell and Amazon, past $600m.

Jun 17, 2019

Quartet uncorks $60m series D

GV and new strategic partner Centene both participated in a round that boosted the collaborative mental healthcare platform’s total funding to $153m.

Jun 17, 2019

Corporates align with Purigen in series B round

Roche participated in the Agilent Technologies-led round, which will fund the launch of Stanford spinout Purigen's isotachophoresis-based DNA and RNA sample preparation platform.

Jun 17, 2019

Blackthorn racks up $76m in series B

The neurobehavioural disorder drug developer sourced funding from investors including Scripps Research, Alphabet, Alexandra Real Estate Equities and Johnson & Johnson in the round.

Jun 17, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here